Franklin Biotechnology Disc A Acc $

Performance History30/04/2015
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund13.324.957.253.416.7
+/-Cat11.40.26.04.9-0.6
+/-Idx-5.6-16.9-3.34.53.0
 
Key Stats
NAV
22/05/2015
 USD 36.44
Day Change 1.08%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
30/04/2015
 USD 2895.09
Share Class Size (Mil)
30/04/2015
 USD 2336.03
Max Initial Charge 5.75%
Ongoing Charge
18/05/2015
  1.81%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns22/05/2015
YTD27.39
3 Years Annualised48.26
5 Years Annualised36.94
10 Years Annualised18.97
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $31/01/2015
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks95.900.0095.90
Bonds0.000.000.00
Cash4.100.004.10
Other0.000.000.00
Top 5 Regions%
United States94.56
United Kingdom2.74
Eurozone1.25
Canada1.16
Europe - ex Euro0.29
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.56
Biogen IncHealthcareHealthcare7.89
Gilead Sciences IncHealthcareHealthcare6.62
Amgen IncHealthcareHealthcare4.64
Medivation IncHealthcareHealthcare3.26
Franklin Biotechnology Disc A Acc $